• Join
  • Login
  • Contact

Search abstracts

Breaking down barriers to patient access; What is needed from stakeholders to bring down barriers to market access in emerging markets

  • At: Glasgow (Scotland) (2018)
  • Type: Presentation
  • By: SOLARIN, Sola (Savanté Consulting, Nigeria)
  • Co-author(s): Sola Solarin
  • Abstract:

    Informed estimate for access to medicines globally is 67%. When disaggregated , emerging market have an average of 50%.

    A number of factors have been identified as responsible for poor access to medicines in emerging markets. They include poor infrastructure, sub-optimal supply chain, policy choices, patents, access to data among others.



  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses